CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Voluson™ ...
Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ...
Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader in Women’s Health Ultrasound Next-generation architecture behind Voluson Expert 22 includes Voluson ...
Latest Voluson Expert 22, 20 and 18 ultrasound systems harness artificial intelligence and advanced tools and software for more efficient assessments Voluson Expert Series delivers elevated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results